JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2025 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2025 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of AN2 Therapeutics, Inc.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2025 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2025 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Trevi Therapeutics, Inc.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2025 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2025 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Eledon Pharmaceuticals, Inc.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2025 • Frazier Life Sciences Public Fund, L.P. • Pharmaceutical preparations
Contract Type FiledFebruary 14th, 2025 Company IndustryPursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, the undersigned hereby agree that only one statement containing the information required by Schedule 13G need be filed with respect to the ownership by each of the undersigned of Common Stock of Puma Biotechnology, Inc.